Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study

Hepatitis

The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study

Am J Gastroenterol

Dukewich M, Dodge JL, Lucey MR, Rice JP, Shetty K, Jakhete N, Im GY, Weinberg EM, Hsu C, Smith C, Ghobrial RM, Therapondos G, Shoreibah M, Aryan M, Eswaran S, Fix OK, Maddur H, Terrault N, Lee BP

doi: 10.14309/ajg.0000000000002956

Hepatology

Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study

Clin Gastroenterol Hepatol

Kabelitz MA, Sandmann L, Praktiknjo M, Mauz JB, Auer TA, Bruns T, Chang J, Fehrenbach U, Hinrichs J, Jansen C, Klöckner R, Kluwe J, Köhler M, Meyer C, Piecha F, Pollmanns MR, Ripoll C, Schultheiss M, Seifert LL, Stöhr F, Sturm L, Trebicka J, Zipprich A, Labenz C, Bettinger D, Maasoumy B, German Cirrhosis Study Group

doi: 10.1016/j.cgh.2025.01.024

Hepatology

Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study

Hepatology

Moeckli B, Wassmer CH, El Hajji S, Kumar R, Rodrigues Ribeiro J, Tabrizian P, Feng H, Schnickel G, Kulkarni AV, Allaire M, Asthana S, Karvellas CJ, Meeberg G, Wei L, Chouik Y, Kumar P, Gartrell R, Martinez M, Kang E, Sogbe M, Sangro B, Schwacha-Eipper B, Schmiderer A, Krendl FJ, Goossens N, Lacotte S, Compagnon P, Toso C

doi: 10.1097/HEP.0000000000001289

Gastrointestinal Cancer

Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study

Hepatology

Xu E, Tabrizian P, Gutierrez J, Hoteit M, Ghaziani T, Zhou K, Parikh N, Ajmera V, Aby E, Shui A, Marino R, Martin A, Wong C, Kao K, Dave S, Florman S, Yao F, Mehta N

doi: 10.1097/HEP.0000000000001231

Hepatology

Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort

J Hepatol

Téllez L, Rincón D, Payancé A, Jaillais A, Lebray P, Rodríguez de Santiago E, Clemente A, Paradis V, Lefort B, Garrido-Lestache E, Prieto R, Iserin L, Tallegas M, Garrido E, Torres M, Muriel A, Perna C, Jesús Del Cerro M, d'Alteroche L, Rautou PE, Bañares R, Albillos A, VALDIG-EASL consortium

doi: 10.1016/j.jhep.2024.09.005

Hepatology

Gender-Equity Model for Liver Allocation using Artificial Intelligence (GEMA-AI) for waiting list liver transplant prioritization

Clin Gastroenterol Hepatol

Gómez-Orellana AM, Rodríguez-Perálvarez ML, Guijo-Rubio D, Gutiérrez PA, Majumdar A, McCaughan GW, Taylor R, Tsochatzis EA, Hervás-Martínez C

doi: 10.1016/j.cgh.2024.12.010

Further Publications

Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study

Lancet Gastroenterol Hepatol

Lindfors A, Strandberg R, Hagström H

doi: 10.1016/S2468-1253(24)00313-3

Hepatology

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

BMC Gastroenterol

Shin WY, Kang ES, Oh YH, Sha M, Xia Q, Jeong S, Cho Y

doi: 10.1186/s12876-025-03814-1

Hepatology

Long-term outcome following liver transplantation of patients with ACLF grade 3

J Hepatol

Artru F, Sacleux SC, Ursic-Bedoya J, Ntandja Wandji LC, Lutu A, L'Hermite S, Levy C, Khaldi M, Levesque E, Dharancy S, Boleslawski E, Lebuffe G, Le Goffic C, Ichai P, Coilly A, De Martin E, Vibert E, Meszaros M, Herrerro A, Monet C, Jaber S, Samuel D, Mathurin P, Labreuche J, Pageaux GP, Saliba F, Louvet A

doi: 10.1016/j.jhep.2024.06.039

Related content

The Survival Benefit of Re-abstinence After Harmful Alcohol Use Following Early Liver Transplant for Severe Alcohol-Associated Hepatitis: A Multi-Center ACCELERATE Study

Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study

Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study

Downstaging of hepatocellular carcinoma before liver transplantation: Results from a national multi-center prospective cohort study

Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort

Gender-Equity Model for Liver Allocation using Artificial Intelligence (GEMA-AI) for waiting list liver transplant prioritization

Screening for advanced liver fibrosis due to metabolic dysfunction-associated steatotic liver disease alongside retina scanning in people with type 2 diabetes: a cross-sectional study

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

Long-term outcome following liver transplantation of patients with ACLF grade 3